Perrigo Co PLC (PRGO)

85.96
NYSE : Health Care
Prev Close 85.80
Day Low/High 85.02 / 86.20
52 Wk Low/High 79.72 / 152.36
Avg Volume 1.86M
Exchange NYSE
Shares Outstanding 143.37M
Market Cap 12.30B
P/E Ratio N/A
Div & Yield 0.58 (0.70%)

Latest News

Perrigo Company Becomes #244 Most Shorted S&P 500 Component, Replacing Noble Energy

Perrigo Company Becomes #244 Most Shorted S&P 500 Component, Replacing Noble Energy

The most recent short interest data has been released for the 10/31/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Perrigo Takes Waterland to Arbitration Over Omega Pharma Acquisition

Perrigo Takes Waterland to Arbitration Over Omega Pharma Acquisition

Perrigo takes a third-quarter writedown of $1.67 billion on its Belgian purchase of two years ago, and will take the private equity firm and Omega's founder to arbitration court.

Valeant Shares Are Destroyed After Disastrous Third Quarter

Valeant Shares Are Destroyed After Disastrous Third Quarter

The troubled drugmaker's new CFO hinted that 2017 top- and bottom-line figures would be lower than 2016 levels.

Stressed Out: Valeant Shareholders Flee on McKesson Warning

Stressed Out: Valeant Shareholders Flee on McKesson Warning

The drugmaker's shares were hammered Friday on news that the industry is slashing prices.

Starboard DepoMed Director Deal Bolsters Sale Prospects

Starboard DepoMed Director Deal Bolsters Sale Prospects

The pain medication maker struck a deal with the fund managed by insurgent Jeff Smith to install a minority-slate of three dissident directors onto its board.

Stressed Out: Free Cash Flow Is All That Counts Now for Valeant

Stressed Out: Free Cash Flow Is All That Counts Now for Valeant

With a $31 billion debt load, the drugmaker has to show it has the firepower needed to fend off creditors.

Stressed Out: Free Cash Flow Is All That Counts Now for Valeant

Stressed Out: Free Cash Flow Is All That Counts Now for Valeant

With a $31 billion debt load, the drugmaker has to show it has the firepower needed to fend off creditors.

Is This Octoberfest? No, It's Chopfest

Statistically, today was not a good day.

Perrigo Could Rake In $2.8 Billion in Tysabri Divestitures, Analysts Say

Perrigo Could Rake In $2.8 Billion in Tysabri Divestitures, Analysts Say

The company could divest non-core assets after Starboard Value revealed a 4.6% stake.

Arbor and Purdue Seen as Likely Bidders for DepoMed

Arbor and Purdue Seen as Likely Bidders for DepoMed

The pharmaceutical company is reportedly up for sale after being dogged by Starboard Value for months, and could go for up to $41 million.

7 Stocks Trading on Big Volume -- and What to Do With Them Now

7 Stocks Trading on Big Volume -- and What to Do With Them Now

Here's a technical look at how to trade some of the most active stocks on the market right now.

Stocks Extend Gains as Fed's Brainard Urges 'Prudence' With Rates; Oil Gains

Stocks Extend Gains as Fed's Brainard Urges 'Prudence' With Rates; Oil Gains

Stocks rise Monday after Federal Reserve Gov. Lael Brainard urges 'prudence' in raising rates.

Midday Report: American Airlines Falls on Weak August Traffic; U.S. Stocks Climb

Midday Report: American Airlines Falls on Weak August Traffic; U.S. Stocks Climb

Stocks climbed, though worries over how soon the Federal Reserve might hike interest rates kept markets wary.

Perrigo Shares Climb on Starboard Value Investment

Perrigo Shares Climb on Starboard Value Investment

The activist fund says Perrigo's promises over the past year have been "woefully unfulfilled."

Stocks Rise but Come Off Highs Amid Rate Hike Worries

Stocks Rise but Come Off Highs Amid Rate Hike Worries

Stocks pare gains on Monday as worries over how soon the Federal Reserve might hike interest rates keeps markets wary.

Perrigo Shares Spike After Starboard's Smith Urges Asset Sales

Perrigo Shares Spike After Starboard's Smith Urges Asset Sales

Perrigo is the second drug company that the activist has targeted in recent months after it rejected an unsolicited bid.

Morning Movers: PRGO, MYL, HPQ, MRO, RIG

Morning Movers: PRGO, MYL, HPQ, MRO, RIG

Falling crude oil prices continued to weigh on markets Monday.

Stock Futures Pare Losses After Fed's Lockhart Stays Coy on Interest Rates

Stock Futures Pare Losses After Fed's Lockhart Stays Coy on Interest Rates

Stock futures moved sharply lower on Monday morning, extending Friday's selloff, as worries continued over how soon the Federal Reserve might hike interest rates.

Perrigo (PRGO) Stock Advances, Starboard Discloses 4.6% Stake

Perrigo (PRGO) Stock Advances, Starboard Discloses 4.6% Stake

Starboard Value disclosed a 4.6% stake in Perrigo (PRGO) stock, and now wants the company to explore a sale of its prescription pharmaceuticals business.

Starboard Discloses 4.6% Ownership In Perrigo And Delivers Letter To The CEO And Board Of Directors

Starboard Discloses 4.6% Ownership In Perrigo And Delivers Letter To The CEO And Board Of Directors

Believes Company Currently Trades at a Significant Discount to Fair Value and That Substantial Opportunities Exist to Create Value for the Benefit of All Shareholders